Sonoma Pharmaceuticals (SNOA) Revenue (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Revenue of $5.6 million for Q1 2026, up 48.14% year-over-year from $3.8 million in Q1 2025, and up 27.87% quarter-over-quarter from $4.3 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Revenue (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Revenue history runs 17 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- In Q1 2026, Revenue rose 48.14% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $19.5 million (up 36.68% YoY), while the FY2026 annual figure was $19.5 million, up 36.68% from the prior year.
- Revenue for Q1 2026 stood at $5.6 million, up from $4.3 million in the prior quarter.
- The five-year high for Revenue was $5.6 million in Q3 2025, with the low at $2.3 million in Q1 2022.
- The 5-year median for Revenue is $3.4 million (2024), against an average of $3.7 million.
- The sharpest annual moves came in 2023 and 2025: Revenue declined 18.01% in 2023, then soared 56.58% in 2025.
- Sonoma Pharmaceuticals' Revenue stood at $2.9 million in 2022, then rose by 6.59% to $3.1 million in 2023, then grew by 13.58% to $3.6 million in 2024, then rose by 22.03% to $4.3 million in 2025, then grew by 27.87% to $5.6 million in 2026.
- Business Quant data shows SNOA's Revenue at $5.6 million in Q1 2026, $4.3 million in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn | 6.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.41 Mn |
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | 4.35 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 3.44 Mn |
| Dec 31, 2023 | 3.14 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 3.43 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 3.74 Mn |